Wells Fargo analyst issues OVERWEIGHT recommendation for HBAN on September 17, 2026 09:58AM ET. The previous analyst recommendation was Overweight.HBAN was trading at $15.82 at issue of the analyst recommendation.The...
Goldman Sachs analyst issues BUY recommendation for CCL on September 17, 2026 10:10AM ET. The previous analyst recommendation was Buy.CCL was trading at $22.35 at issue of the analyst recommendation.The...
Cowen & Co. analyst issues BUY recommendation for CRM on September 17, 2026 10:18AM ET. The previous analyst recommendation was Buy.CRM was trading at $250.54 at issue of the analyst...
Bernstein analyst issues MARKET PERFORM recommendation for FTNT on September 17, 2026 10:23AM ET. The previous analyst recommendation was Market Perform.FTNT was trading at $171.77 at issue of the analyst...
Guggenheim analyst issues BUY recommendation for CRM on September 17, 2026 10:43AM ET. The previous analyst recommendation was Buy.CRM was trading at $250.54 at issue of the analyst recommendation.The overall...
Oppenheimer analyst issues OUTPERFORM recommendation for CRM on September 17, 2026 10:32AM ET. The previous analyst recommendation was Outperform.CRM was trading at $250.54 at issue of the analyst recommendation.The overall...
Citigroup analyst issues NEUTRAL recommendation for CRM on September 17, 2026 09:36AM ET. The previous analyst recommendation was Neutral.CRM was trading at $250.54 at issue of the analyst recommendation.The overall...
Evercore ISI analyst issues OUTPERFORM recommendation for GOOGL on September 16, 2026 10:18PM ET. The previous analyst recommendation was Outperform.GOOGL was trading at $342.87 at issue of the analyst recommendation.The...
Barclays analyst issues OVERWEIGHT recommendation for INTC on September 16, 2026 12:57PM ET. The previous analyst recommendation was Underperform.INTC was trading at $101.4001 at issue of the analyst recommendation.The overall...
Raymond James analyst issues OUTPERFORM recommendation for CVE on September 16, 2026 12:19PM ET. The previous analyst recommendation was Outperform.CVE was trading at $33.92 at issue of the analyst recommendation.The...
